香港股市 已收市

Laboratory Corporation of America Holdings (LH)

NYSE - Nasdaq 即時價格。貨幣為 USD。
加入追蹤清單
237.96-1.82 (-0.76%)
市場開市。 截至 09:53AM EST。

Laboratory Corporation of America Holdings

358 South Main Street
Burlington, NC 27215
United States
336 229 1127
https://www.labcorp.com

版塊Healthcare
行業Diagnostics & Research
全職員工75,000

高階主管

名稱標題支付行使價出生年份
Mr. Adam H. SchechterPres, CEO & Chairman5.51M1965
Mr. Glenn A. EisenbergCFO & Exec. VP2.3M1961
Dr. Brian J. Caveney M.P.H., M.D., J.D., MPHExec. VP, Pres of Diagnostics & Chief Medical Officer1.57M1974
Mr. Mark S. SchroederExec. VP and Pres of Diagnostics Laboratory Operations & Global Supply Chain1.59M1961
Dr. Paul R. Kirchgraber M.D.Exec. VP & CEO of Covance Drug Devel.2.02M1962
Dr. Michelle Abelson Ph.D.Laboratory Director of Operations
Mr. Peter J. WilkinsonSr. VP & Chief Accounting Officer1972
Mr. Lance V. BerberianExec. VP and Chief Information & Technology Officer1963
Dr. Marcia T. Eisenberg Ph.D.Chief Scientific Officer & Sr. VP1960
Chas CookVP of Investor Relations
截止 2021年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

公司管治

截至 2022年11月28日 止,Laboratory Corporation of America Holdings 的 ISS 管治質素評分為 1。 Pillar 分數正在審核中:8;董事會:7;股東權利:1;現金賠償:1。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。